Mochida Pharmaceutical Sees Mixed Q1 Results, Stable Outlook

Mochida Pharmaceutical Co., Ltd. (JP:4534) has released an update.

Mochida Pharmaceutical Co., Ltd. reported modest growth in net sales at 2.7% year-on-year in the first quarter ended June 30, 2024, despite a decline in operating profit, ordinary profit, and profit attributable to owners by 13.0%, 8.7%, and 7.9%, respectively. The company’s total assets remain stable, and they forecast a positive outlook for the full fiscal year, expecting increases in profits and earnings per share. No changes to the dividend forecast were announced, maintaining the previous year’s total of 80.00 yen per share.

For further insights into JP:4534 stock, check out TipRanks’ Stock Analysis page.